Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.40 |
| ▸ | NPY1R | P25929 | 7/20 | 0.40 |
| ▸ | NPY2R | P49146 | 5/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.39 |
| ▸ | FURIN | P09958 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31265333 | 0.94 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RSMN1; SMN2 | |
| SCHEMBL30455090 | 0.93 | NPY5R (0.40) | NPY4RNPY1RNPY5RENPEP | |
| SCHEMBL29379387 | 0.92 | ENPEP (0.43) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL31127564 | 0.91 | FNTA (0.38) | ENPEP | |
| SCHEMBL31147167 | 0.91 | FNTA (0.38) | ENPEP | |
| SCHEMBL31277463 | 0.90 | ENPEP (0.46) | ENPEP | |
| SCHEMBL30303032 | 0.90 | ENPEP (0.46) | ENPEP | |
| SCHEMBL29625209 | 0.90 | ENPEP (0.48) | ENPEP | |
| SCHEMBL30092240 | 0.90 | ENPEP (0.49) | ENPEP | |
| SCHEMBL31127560 | 0.89 | FNTA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381324-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2025-12-18 | — | — | US | disclosed |
| US-20250281679-A1 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2025-09-11 | — | — | US | disclosed |
| EP-4440644-A2 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-10-09 | — | — | EP | disclosed |
| EP-4440643-A2 | MEDICAL DEVICE WITH CD31 MIMETIC COATING | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-10-09 | — | — | EP | disclosed |
| WO-2023099932-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023099748-A2 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023099957-A2 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381324-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | SELE, VCAM1, SELP | NPY4R 1217/4885NPY1R 726/4885NPY2R 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.